Cyclohexanamine ((2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl phosphate)(2:1)

Catalog No. :
ACNKQJ834
CAS No. :
102783-28-8
Molecular Formula :
C17H37N2O7P
Molecular Weight :
412.46

IUPAC Name:cyclohexanamine hemi((2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl phosphate)

Cyclohexanamine ((2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl phosphate)(2:1) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameCyclohexanamine ((2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl phosphate)(2:1)
IUPAC Namecyclohexanamine hemi((2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl phosphate)
Molecular FormulaC17H37N2O7P
Molecular Weight412.46
SMILESNC1CCCCC1.O=P(O)(O)O[C@@H]2O[C@H](CO)[C@@H](O)C2.NC3CCCCC3
InChI KeyGVYUZZDUVZHJAM-GBLUYGQPSA-N
Synonym2-DEOXY-ALPHA-D-RIBOSE 1-PHOSPHATE BIS(CYCLOHEXYLAMINE) SALT;2-DEOXY-ALPHA-D-RIBOSE 1-PHOSPHATE DI(MONOCYCLOHEXYL-AMMONIUM) SALT;2-DEOXY-A-D-RIBOSE 1-PHOSPHATE*DI(MONOCY CLOHEXYLAMM;2-DEOXY-ALPHA-D-RIBOSE1-PHOSPHATE BIS &;2-deoxy-α-d-ribose 1-phosphate bis(cyclohexylammonium) salt;2-Deoxy-α-D-ribose1-phosphatebis(cyclohexylamine)salt;2-Deoxy-á-D-ribose-1-phosphate di(monocyclohexylammonium) salt;2-deoxy-alpha-D-ribose-1-phosphate bis(cyclohexylamine)
CAS No.102783-28-8
PubChem CID11486737

Synthetic Route by SureRoute

1. ACNKQJ834 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNKQJ834 route product structure diagram
    ACNKQJ834102783-28-8
Inquiry

2. ACNKQJ834 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNKQJ834 route product structure diagram
    ACNKQJ834102783-28-8
Inquiry

Comments (0)